209 related articles for article (PubMed ID: 33620517)
21. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
22. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
24. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
Mitu GM; Wang S; Hirschberg R
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1641-8. PubMed ID: 17804487
[TBL] [Abstract][Full Text] [Related]
25. Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.
Zhang H; Nair V; Saha J; Atkins KB; Hodgin JB; Saunders TL; Myers MG; Werner T; Kretzler M; Brosius FC
Kidney Int; 2017 Oct; 92(4):909-921. PubMed ID: 28554737
[TBL] [Abstract][Full Text] [Related]
26. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-218 promotes high glucose-induced apoptosis in podocytes by targeting heme oxygenase-1.
Yang H; Wang Q; Li S
Biochem Biophys Res Commun; 2016 Mar; 471(4):582-8. PubMed ID: 26876575
[TBL] [Abstract][Full Text] [Related]
28. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
29. Metadherin facilitates podocyte apoptosis in diabetic nephropathy.
Liu WT; Peng FF; Li HY; Chen XW; Gong WQ; Chen WJ; Chen YH; Li PL; Li ST; Xu ZZ; Long HB
Cell Death Dis; 2016 Nov; 7(11):e2477. PubMed ID: 27882943
[TBL] [Abstract][Full Text] [Related]
30. Podocyte and endothelial-specific elimination of BAMBI identifies differential transforming growth factor-β pathways contributing to diabetic glomerulopathy.
Lai H; Chen A; Cai H; Fu J; Salem F; Li Y; He JC; Schlondorff D; Lee K
Kidney Int; 2020 Sep; 98(3):601-614. PubMed ID: 32739209
[TBL] [Abstract][Full Text] [Related]
31. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
[TBL] [Abstract][Full Text] [Related]
32. Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.
Chitra PS; Swathi T; Sahay R; Reddy GB; Menon RK; Kumar PA
J Cell Biochem; 2015 Sep; 116(9):1947-56. PubMed ID: 25740786
[TBL] [Abstract][Full Text] [Related]
33. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
[TBL] [Abstract][Full Text] [Related]
35. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
[TBL] [Abstract][Full Text] [Related]
37. Formyl peptide receptor 1 promotes podocyte injury through regulation of mitogen-activated protein kinase pathways.
Zhang J; Ding T; Tang D; Wang J; Huang P
Exp Biol Med (Maywood); 2022 Jan; 247(2):87-96. PubMed ID: 34565207
[TBL] [Abstract][Full Text] [Related]
38. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
Peters I; Tossidou I; Achenbach J; Woroniecki R; Mengel M; Park JK; Paschy M; de Groot K; Haller H; Schiffer M
J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
[TBL] [Abstract][Full Text] [Related]
39. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-21 in glomerular injury.
Lai JY; Luo J; O'Connor C; Jing X; Nair V; Ju W; Randolph A; Ben-Dov IZ; Matar RN; Briskin D; Zavadil J; Nelson RG; Tuschl T; Brosius FC; Kretzler M; Bitzer M
J Am Soc Nephrol; 2015 Apr; 26(4):805-16. PubMed ID: 25145934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
